The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection - Wikidata - wikimedia - TriplyDB

The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection

The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection

http://www.wikidata.org/entity/Q27488224

about

Mechanism and significance of cell type-dependent neutralization of flaviviruses Shake, rattle, and roll: Impact of the dynamics of flavivirus particles on their interactions with the host Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections Role of dendritic cells in antibody-dependent enhancement of dengue virus infection Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy Broadly Neutralizing Activity of Zika Virus-Immune Sera Identifies a Single Viral Serotype Degrees of maturity: the complex structure and biology of flaviviruses Mouse models to study dengue virus immunology and pathogenesis Dengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral Serotypes Rational design of a live attenuated dengue vaccine: 2'-o-methyltransferase mutants are highly attenuated and immunogenic in mice and macaques How antibodies alter the cell entry pathway of dengue virus particles in macrophages Development of a highly protective combination monoclonal antibody therapy against Chikungunya virus Induction of Epitope-Specific Neutralizing Antibodies against West Nile Virus Epitope Determinants of a Chimpanzee Dengue Virus Type 4 (DENV-4)-Neutralizing Antibody and Protection against DENV-4 Challenge in Mice and Rhesus Monkeys by Passively Transferred Humanized Antibody Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes Complement Protein C1q Inhibits Antibody-Dependent Enhancement of Flavivirus Infection in an IgG Subclass-Specific Manner Maturation of West Nile Virus Modulates Sensitivity to Antibody-Mediated Neutralization Humanized Monoclonal Antibodies Derived from Chimpanzee Fabs Protect against Japanese Encephalitis Virus In Vitro and In Vivo Characterization of Dengue Virus Complex-Specific Neutralizing Epitopes on Envelope Protein Domain III of Dengue 2 Virus Closing the door on flaviviruses: Entry as a target for antiviral drug design The structural immunology of antibody protection against West Nile virus Molecular mechanisms of antibody-mediated neutralisation of flavivirus infection Structural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine Development A Therapeutic Antibody against West Nile Virus Neutralizes Infection by Blocking Fusion within Endosomes West Nile Virus Capsid Degradation of Claudin Proteins Disrupts Epithelial Barrier Function Human Monoclonal Antibodies against West Nile Virus Induced by Natural Infection Neutralize at a Postattachment Step Antibodies against viruses: passive and active immunization Development of Resistance to Passive Therapy with a Potently Neutralizing Humanized Monoclonal Antibody against West Nile Virus Complement modulates pathogenesis and antibody-dependent neutralization of West Nile virus infection through a C5-independent mechanism Progress on the development of therapeutics against West Nile virus A Prospective Nested Case-Control Study of Dengue in Infants: Rethinking and Refining the Antibody-Dependent Enhancement Dengue Hemorrhagic Fever Model Complement Protein C1q Reduces the Stoichiometric Threshold for Antibody-Mediated Neutralization of West Nile Virus Protonation of Individual Histidine Residues Is Not Required for the pH-Dependent Entry of West Nile Virus: Evaluation of the "Histidine Switch" Hypothesis The relationship of interacting immunological components in dengue pathogenesis Monoclonal antibody produced in plants efficiently treats West Nile virus infection in mice Enhanced Infection of Liver Sinusoidal Endothelial Cells in a Mouse Model of Antibody-Induced Severe Dengue Disease The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1 Peptide Inhibitors of Dengue-Virus Entry Target a Late-Stage Fusion Intermediate Deconstructing the Antiviral Neutralizing-Antibody Response: Implications for Vaccine Development and Immunity Structural Basis of Differential Neutralization of DENV-1 Genotypes by an Antibody that Recognizes a Cryptic Epitope

P2860

Q23032973-3187A048-50F1-46A8-81D1-18FE75C9E39C Q23925011-BA0D436C-6370-4D64-B9A0-C464CEA64330 Q24289014-BD21B228-338C-4BBD-B2FA-EC02F36DBED9 Q24655655-66648C9A-3757-45B6-A152-109136180DDA Q24701766-CEBD6D3B-7C1F-4F3D-B349-75983AB159A8 Q26252060-AE3A79BB-F583-4BB4-9775-B35FF9304981 Q26824712-EBBA8E5E-3463-4203-83AF-6AB1745442C7 Q27010151-53318E1E-5AB0-41E1-8D0B-587C2A975206 Q27304342-CB48EA01-FCD9-4C56-8574-42E1904C2BCE Q27334248-41ED52D2-C817-4726-BFD7-909A008AD97F Q27334575-52040731-28DF-422B-8AA1-7D19179EAB34 Q27335008-5FD1C3D8-B423-4EE3-ACE6-B81C7C75009C Q27484980-5184C4F7-14D4-4AEC-B05C-B144E6C8C96B Q27485025-8542B373-45A1-4C6D-9A7D-CE0CA6A689F7 Q27485031-BC6FD5F2-7FB0-425C-AE90-49E897569F40 Q27485131-BC611F77-D736-4166-A7AD-F46F2799C864 Q27485890-3B3B655B-8CAC-4A7B-9A2A-ED5F82FD6C46 Q27486404-F7030E5D-ED88-41C9-A3BB-A4021325DF61 Q27486788-6494B303-1A82-4D61-98F5-C778963B5F1C Q27487953-48CFE19E-C002-4840-A691-448B6A48CA25 Q27487955-EBB908E5-BA2B-4EAB-9267-CD6471A2C4AB Q27488337-254269A8-C7BC-4E92-8ABF-B928D0932B77 Q27488364-66F484A5-0076-4E53-A363-153BD94853C0 Q27488367-FE656D6E-3A44-4FB2-B419-DB0E17F76E17 Q27488431-5F1FF0A8-CCFC-49E6-8A12-08D6C4F230B2 Q27488791-FAEDFFAC-DCF2-4D96-8D7F-9FF0C2563336 Q27489392-5F417E90-D9FA-4E60-A941-2303DDAB7AF1 Q27489782-71856C3E-558D-4AAF-9ACA-ABD284F15E23 Q27489809-246A2DF5-7FE4-43B3-BBF6-E87D8294137B Q27489893-EA1BD8E8-08E7-4735-909B-5F75392B8A87 Q27490166-E7A630AB-28C6-423D-BAEF-7F8DB28587C9 Q27490423-6588384C-0DE8-4AA5-A74A-7A3E9D99EF1D Q27490468-144C0123-8403-4B91-BDFC-0E08E9369770 Q27490496-53B019C6-8522-426E-AD8A-1F395BFE1B72 Q27490937-6A8AA080-B0B0-44A5-AD88-48F22BD5AF28 Q27490947-C431D2A8-8106-42F8-8DE3-0B9319522904 Q27491317-888001DB-C125-47D5-9000-35664B4D7FEE Q27491339-354BD528-6C65-4564-8071-8F1078C00EDF Q27654848-D295E838-6F42-4BDE-A9EA-8CFDF8FCE9C3 Q27674417-488B1992-FC1B-43B5-802B-ECC51A3FFFD1

P2860

The Stoichiometry of Antibody-Mediated Neutralization and Enhancement of West Nile Virus Infection

http://www.wikidata.org/entity/Q27488224

description

2007 nî lūn-bûn

@nan

2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

The Stoichiometry of Antibody- ...... t of West Nile Virus Infection

@ast

The Stoichiometry of Antibody- ...... t of West Nile Virus Infection

@en

The Stoichiometry of Antibody- ...... t of West Nile Virus Infection

@nl

type

label

The Stoichiometry of Antibody- ...... t of West Nile Virus Infection

@ast

The Stoichiometry of Antibody- ...... t of West Nile Virus Infection

@en

The Stoichiometry of Antibody- ...... t of West Nile Virus Infection

@nl

prefLabel

The Stoichiometry of Antibody- ...... t of West Nile Virus Infection

@ast

The Stoichiometry of Antibody- ...... t of West Nile Virus Infection

@en

The Stoichiometry of Antibody- ...... t of West Nile Virus Infection

@nl

P1433

Q27488224-A4BDBE8D-1BD1-44B4-ADCD-4E808E3BD37E

P1476

Q27488224-8A466963-F8D0-42DE-847D-B47E1953F5D8

P2093

Q27488224-249F2857-C6B0-4FBA-B051-CEEF610D4871

Q27488224-47425F33-2C33-4574-8975-50669D8690FD

Q27488224-5045358D-1D21-4C5D-81AF-A72E7F7D90E4

Q27488224-CF86E4D1-0ADB-4E1D-925B-ABAC463FC1D4

P2860

Q27488224-02E8C994-84AF-4B64-9092-744EE7A20DAD

Q27488224-061C2E0E-FEC8-4CBB-9016-957EA04C946D

Q27488224-06CE65D9-A889-479D-A2FD-6503470AE2CA

Q27488224-0D8A9A77-AFA9-48FB-87B9-DD54FCA05AC8

Q27488224-0DBA9288-7D88-4676-BD54-535C5D5CC2B9

Q27488224-0E614D75-8240-4404-AA26-FAC3DCFB3497

Q27488224-0F6075E7-361D-422C-95B5-8D9E07011FB3

Q27488224-10B8E012-025B-4AC1-8072-F0F19FD254F4

Q27488224-12BC86E0-4094-4F8C-A849-A8A725003A73

Q27488224-134BC81A-43EF-4DF3-967A-39C08DBC7296

P304

Q27488224-E85EEBBB-162E-47A8-97F4-C3343FD4E7C4

P31

Q27488224-48AB2F36-102C-4892-A453-721E4EC2B792

P3181

Q27488224-863B0296-F0C0-419D-8E16-DB7E1167BD65

P356

Q27488224-4F92C26E-E16F-4737-A66C-C4B7A546FE9D

P433

Q27488224-B868404E-B0D6-4FFC-B27F-E8D763909200

P478

Q27488224-68A9E7E4-5555-4452-9098-3B4B3B2534D7

P50

Q27488224-04C02BDE-EFC6-4613-8083-33DAA615EDB1

Q27488224-72A9BCB7-C553-4419-A21F-889242A61CDB

Q27488224-737A93C8-421A-4DEE-AF7F-B9A5EC28FF43

P5008

Q27488224-13821CC8-BC03-4A87-8AF9-4819E088AF5C

P577

Q27488224-3E87F32F-EEE3-490C-9059-CEEA425BCD9C

P5875

Q27488224-AEE8779D-DA77-4165-93CA-91087C6B7497

P698

Q27488224-70BA9B43-818F-4DAA-90D7-E28BA91F762A

P921

Q27488224-41F4CFB2-FC89-43B8-83F5-CE21AFD6B373

Q27488224-50729DB3-9893-4F16-A4DA-534C296C1F69

Q27488224-A59CD84B-82E3-4207-9459-DF9841B00601

P932

Q27488224-32B23145-3F29-4506-91C5-C625024FD405

P3181

P356

J.CHOM.2007.03.002

P1433

Cell Host & Microbe

P1476

The Stoichiometry of Antibody- ...... t of West Nile Virus Infection

@en

P2093

Daved H Fremont

http://www.w3.org/2001/XMLSchema#string

Grant E Nybakken

http://www.w3.org/2001/XMLSchema#string

Qing Xu

http://www.w3.org/2001/XMLSchema#string

Steevenson Nelson

http://www.w3.org/2001/XMLSchema#string

P2860

Epidemiology and transmission dynamics of West Nile virus disease

Structure of dengue virus: implications for flavivirus organization, maturation, and fusion

Mutational Evidence for an Internal Fusion Peptide in Flavivirus Envelope Protein E

Biophysical Characterization and Vector-Specific Antagonist Activity of Domain III of the Tick-Borne Flavivirus Envelope Protein

Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus

West Nile Virus Discriminates between DC-SIGN and DC-SIGNR for Cellular Attachment and Infection

Identification of neutralizing epitopes within structural domain III of the West Nile virus envelope protein.

B cells and antibody play critical roles in the immediate defense of disseminated infection by West Nile encephalitis virus.

Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus

West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody

P304

135-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

199651

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.CHOM.2007.03.002

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P50

Michael S. Diamond

Theodore C Pierson

Theodore Oliphant

P5008

P577

2007-04-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5840737

http://www.w3.org/2001/XMLSchema#string

P698

18005691

http://www.w3.org/2001/XMLSchema#string

P921

West Nile virus

P932

2656919

http://www.w3.org/2001/XMLSchema#string